The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[(4-Ethoxy-3-methoxy-phenylamino)-methyl]-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamine ID: ALA358195
PubChem CID: 44366644
Max Phase: Preclinical
Molecular Formula: C18H22N6O2
Molecular Weight: 354.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccc(NCc2cnc3nc(N)nc(N)c3c2C)cc1OC
Standard InChI: InChI=1S/C18H22N6O2/c1-4-26-13-6-5-12(7-14(13)25-3)21-8-11-9-22-17-15(10(11)2)16(19)23-18(20)24-17/h5-7,9,21H,4,8H2,1-3H3,(H4,19,20,22,23,24)
Standard InChI Key: IOOOPIQISFLCNT-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
1.0250 -5.1375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4083 -4.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3042 -5.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0250 -4.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3042 -3.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4083 -5.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7417 -5.5500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7292 -3.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4417 -4.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0167 -3.8750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3042 -4.2917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4542 -5.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0125 -3.0500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1625 -3.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8792 -4.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3042 -3.0750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5917 -3.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1208 -5.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2917 -2.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5792 -3.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -4.2792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7250 -2.6292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7292 -3.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4417 -3.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7375 -5.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4417 -3.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 2 0
4 1 1 0
5 4 2 0
6 3 1 0
7 1 1 0
8 4 1 0
9 12 1 0
10 11 1 0
11 17 2 0
12 7 2 0
13 19 1 0
14 9 1 0
15 14 1 0
16 5 1 0
17 15 1 0
18 6 1 0
19 20 2 0
20 17 1 0
21 10 1 0
22 13 1 0
23 8 1 0
24 22 1 0
25 21 1 0
26 24 1 0
2 6 2 0
8 9 2 0
13 10 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.41Molecular Weight (Monoisotopic): 354.1804AlogP: 2.52#Rotatable Bonds: 6Polar Surface Area: 121.20Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 4.49CX LogP: 1.90CX LogD: 1.90Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.62Np Likeness Score: -0.93
References 1. Debnath AK.. (2002) Pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors of Mycobacterium avium complex dihydrofolate reductase., 45 (1): [PMID:11754578 ] [10.1021/jm010360c ]